Home › Products › Diabetes › Empasov 25mg Tablet
Empasov 25mg Tablet
Salt Composition: EMPAGLIFLOZIN
- Manufacturer: CIPLA LTD
- Pack Size: 10 TABLET(s) IN A STRIP
- Dosage Form: TABLET
- Strength: 25MG
- Prescription Required
- Storage: Store Empasov 25mg Tablet at room temperature (20°C to 25°C) in a dry place, away from moisture and heat. If a dose is missed, take it as soon as remembered. If it is near the time of the next dose, skip the missed dose. Do not double the dose. Seek immediate medical attention if an overdose is suspected. Symptoms may include excessive urination, dehydration, dizziness, or hypoglycemia. Keep out of reach of children and do not share medication with others.
₹127.00₹140.53
Inclusive of all taxes
Product Introduction
Empasov 25mg Tablet is an oral medication belonging to the pharmacological class of sodium-glucose co-transporter-2 (SGLT2) inhibitors. It is primarily used for managing type 2 diabetes mellitus by improving glycemic control. Additionally, it may help reduce the risk of cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. Empasov 25mg Tablet is available in tablet form and is typically administered once daily, with or without food. Empasov 25mg Tablet works by blocking SGLT2 proteins in the kidneys, preventing glucose reabsorption and promoting glucose excretion through urine. While Empasov 25mg Tablet is generally considered safe for most individuals, caution should be exercised in patients with renal impairment, those with a history of diabetic ketoacidosis, or individuals with hypersensitivity to the active constituent. It is contraindicated during pregnancy and breastfeeding unless specifically advised by a healthcare provider.
Uses
Management of type 2 diabetes mellitus to improve glycemic control. Reduction of cardiovascular risk in adults with type 2 diabetes and established cardiovascular disease. Potential benefits in managing heart failure and chronic kidney disease (as recommended by healthcare professionals).
How it works
Empasov 25mg Tablet works by inhibiting the SGLT2 proteins located in the proximal renal tubules of the kidneys. By blocking these proteins, it reduces glucose reabsorption and promotes the excretion of excess glucose through urine. This mechanism helps lower blood sugar levels effectively and provides cardiovascular and renal protective benefits. Additionally, Empasov 25mg Tablet may help reduce body weight and blood pressure as secondary effects, which are beneficial for patients with type 2 diabetes.
How to Use
Empasov 25mg Tablet is available in tablet form, typically taken once daily, with or without food. Swallow the tablet whole with water. Adhere to the prescribed dosage as instructed by your healthcare provider. Do not alter or discontinue the medication without professional guidance.
Side Effects
Common Side Effects Increased urination Thirst Dizziness Genital yeast infections (especially in women) Urinary tract infections Serious Side Effects Severe hypoglycemia (when combined with insulin or insulin secretagogues) Ketoacidosis (rare but serious) Acute kidney injury Severe allergic reactions (rash, itching, swelling)
Expert Tips
Patients using Empasov 25mg Tablet should remain adequately hydrated and monitor their blood sugar levels regularly. It is essential to attend routine check-ups and discuss any unusual symptoms with a healthcare provider. Avoid using the medication if you have a history of severe kidney problems or diabetic ketoacidosis.
References
- 1. Sizar O, Podder V, Talati R. Empagliflozin. [Updated 2023 May 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532925/ 2. Forycka J, Hajdys J, KrzemiÅska J, Wilczopolski P, Wronka M, MÅynarska E, Rysz J, Franczyk B. New Insights into the Use of Empagliflozin-A Comprehensive Review. https://pmc.ncbi.nlm.nih.gov/articles/PMC9775057/ 3. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204629s033lbl.pdf 4. https://www.ema.europa.eu/en/documents/product-information/jardiance-epar-product-information_en.pdf
Safety Advice
Pregnancy: unsafe Empasov 25mg Tablet should be avoided during pregnancy unless prescribed by a healthcare provider. Limited data suggests potential harm to the developing fetus.
Lungs: safe Empasov 25mg Tablet does not have known adverse effects on lung function.
Breastfeeding: Consult your doctor It is unknown whether Empasov 25mg Tablet passes into breast milk. Avoid use or consult a healthcare provider for advice.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.